Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/14/22
End: 10/18/23
Due: 10/18/24
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/15/23
End: 08/31/24
Due: 08/31/25
Phase: N/A
Priority: Normal
Start: 09/08/20
End: 07/01/23
Due: 07/01/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Zofin to Treat COVID-19 Long Haulers | NCT05228899 | ZEO ScientifiX, Inc. | user2@example.com | None | 2022-04-14 | 2023-10-18 | 2024-10-18 | - | - | 2025-07-14 |
| Expanded Access to Zofin for Patients With COVID-19 | NCT04657406 | ZEO ScientifiX, Inc. | user2@example.com | None | - | - | - | - | - | 2025-07-14 |
| Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD) | NCT05643729 | ZEO ScientifiX, Inc. | user2@example.com | None | 2023-11-15 | 2024-08-31 | 2025-08-31 | - | - | 2025-07-14 |
| Zofin (Organicell Flow) for Patients With COVID-19 | NCT04384445 | ZEO ScientifiX, Inc. | user2@example.com | None | 2020-09-08 | 2023-07-01 | 2024-07-01 | - | - | 2025-07-14 |